Molecular basis for the transport of cytochrome P450 2E1 to the plasma membrane

被引:58
|
作者
Neve, EPA [1 ]
Ingelman-Sundberg, M [1 ]
机构
[1] Karolinska Inst, Natl Inst Environm Med, Div Mol Toxicol, S-17177 Stockholm, Sweden
关键词
D O I
10.1074/jbc.M000957200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endoplasmic reticulum-resident cytochrome P450 enzymes that face the cytosol are present on the plasma membrane of hepatocytes, but the molecular origin for their transport to this compartment has until now remained unknown. The molecular basis for the transport of rat ethanol-inducible cytochrome P450 2E1 (CYP2E1) to the plasma membrane was investigated by transfection of several different mutant cDNAs into mouse H2.35 hepatoma cells. Two NH2-terminal CYP2E1 mutants were constructed: N(++)2E1, which carried two positive charges in the NH, terminus, and 2C-2E1, in which the transmembrane domain of CYP2E1 was replaced with that of CYP2C1, which was previously described to cause retention of CYP2C1 in the endoplasmic reticulum, as well as CYP2E1 COOH-terminally tagged with the vesicular stomatitis virus G protein (VSV-G) epitope (2E1-VSV-G). Immunofluorescent microscopy and cell surface biotinylation experiments revealed that all CYP2E1 variants were present on the extracellular side of the plasma membrane. The VSV-G epitope on CYP2E1 was detected on the outside of the plasma membrane using VSV-G-specific antibodies, indicating that the large COOH-terminal part of CYP2E1 is indeed exposed on the outside of the plasma membrane. The relative levels of CYP2E1, 2C-2E1, and 2E1-VSV-G on the cell surface were found to be about 2% of total cellular enzyme, whereas twice this amount of N(++)2E1 was recovered at the cell surface. Protease protection experiments performed on microsomes isolated from cDNA transfected cells revealed that a small fraction of CYP2E1 and all variant proteins was found to be located in the lumen of the endoplasmic reticulum (type II orientation), whereas the majority of the proteins were in the expected cytosolic or type I orientation. It is concluded that the NH2-terminal transmembrane domain of CYP2E1 plays a critical role in directing the protein to the cell surface and that topological inversion of a small fraction of CYP2E1 in the endoplasmic reticulum directs the protein to the plasma membrane.
引用
收藏
页码:17130 / 17135
页数:6
相关论文
共 50 条
  • [1] Inactivation of cytochrome P450 2E1 by capsaicin
    Smeal, SJ
    Reilly, CA
    Yost, GS
    FASEB JOURNAL, 2002, 16 (05): : A940 - A941
  • [2] Human and minipig cytochrome P450 2E1
    Baranová, J
    Anzenbacherová, E
    Zuber, R
    Anzenbacher, P
    Soucek, P
    CYTOCHROMES P450, BIOCHEMISTRY, BIOPHYSICS AND DRUG METABOLISM, 2003, : 143 - 147
  • [3] Molecular basis for a functional role of cytochrome P450 2E1 in non-alcoholic steatohepatitis
    Wu, Chung W.
    Yu, Jun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (06) : 1019 - 1020
  • [4] Molecular evidence for cytochrome P450 2E1 expressed in human brain
    Yoo, M
    Shin, SW
    KOREAN JOURNAL OF GENETICS, 1998, 20 (03): : 183 - 189
  • [5] Molecular Basis of the Recognition of Arachidonic Acid by Cytochrome P450 2E1 Along Major Access Tunnel
    Cui, Ying-Lu
    Zheng, Qing-Chuan
    Zhang, Ji-Long
    Zhang, Hong-Xing
    BIOPOLYMERS, 2015, 103 (01) : 53 - 66
  • [6] Phenotyping of cytochrome P450 2E1 in vitro and in vivo
    Ernstgard, Lena
    Johanson, Gunnar
    Karlsson, Anne-Sophie
    Warholm, Margareta
    CURRENT DRUG METABOLISM, 2007, 8 (05) : 493 - 498
  • [7] Genetic polymorphism of human cytochrome P450 2E1
    Nedelcheva, V
    Persson, I
    IngelmanSundberg, M
    CYTOCHROME P450, PT B, 1996, 272 : 218 - 225
  • [8] Inactivation of cytochrome P450 2E1 by benzyl isothiocyanate
    Moreno, RL
    Kent, UM
    Hodge, K
    Hollenberg, PF
    CHEMICAL RESEARCH IN TOXICOLOGY, 1999, 12 (07) : 582 - 587
  • [9] Cytochrome P450 2E1 and its roles in disease
    Guengerich, F. Peter
    CHEMICO-BIOLOGICAL INTERACTIONS, 2020, 322
  • [10] Clinical isoflurane metabolism by cytochrome P450 2E1
    Kharasch, ED
    Hankins, DC
    Cox, K
    ANESTHESIOLOGY, 1999, 90 (03) : 766 - 771